Co-Diagnostics, Inc. (CODX): Nasdaq/NYSE listing notice — Co-Diagnostics receives Nasdaq bid price deficiency notice; 180 days to regain compliance

Co-Diagnostics, Inc.

Notice on Jan 10, 2025: closing bid price below $1.00 for 30 consecutive business days.
Compliance date July 9, 2025; must close at $1.00+ for ten consecutive business days.
Stock continues trading on Nasdaq Capital Market under symbol CODX.
If not compliant by July 9, may seek 180-day extension by meeting other listing standards and intending reverse split if needed.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Co-Diagnostics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 10, 2025, Co-Diagnostics, Inc. (“CODX” or “the Company”) received a notice from Nasdaq Listing Qualifications department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the closing bid price

View on SEC.gov

97 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Co-Diagnostics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-001705

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.